PRESS RELEASE published on 04/28/2026 at 12:30, 6 months 9 days ago Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity Chief Medical Officer Immunic Neurology Commercial-stage Michael A. Panzara
BRIEF published on 04/23/2026 at 14:05, 6 months 14 days ago Immunic, Inc. annonce un regroupement d'actions à raison de 1 pour 10 Immunic Inc. Regroupement D'actions Inversé Assemblée Générale Des Actionnaires Réduction Des Parts Nasdaq IMUX
BRIEF published on 04/23/2026 at 14:05, 6 months 14 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Reverse Stock Split Immunic Inc. Stockholder Meeting Share Reduction Nasdaq IMUX
PRESS RELEASE published on 04/23/2026 at 14:00, 6 months 14 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Immunic, Inc. announces a 1-for-10 reverse stock split to meet contractual obligations, reducing outstanding shares from 136M to 13.6M Shareholders Reverse Stock Split Nasdaq Immunic Inc. Neurologic Diseases
BRIEF published on 04/09/2026 at 12:35, 6 months 28 days ago Immunic participera à des conférences scientifiques majeures en avril Biotechnologie Conférences Essais Cliniques Thérapies Orales Neurologie
BRIEF published on 04/09/2026 at 12:35, 6 months 28 days ago Immunic to Engage in Key Scientific Conferences in April Biotechnology Clinical Trials Conférences Oral Therapies Neurology
PRESS RELEASE published on 04/09/2026 at 12:30, 6 months 28 days ago Immunic to Participate in Scientific and Medical Conferences in April Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF published on 04/01/2026 at 12:35, 7 months 6 days ago Immunic obtient la conformité au Nasdaq Biotechnologie Marché Boursier Immunitaire Conformité NASDAQ Thérapies Neurologiques
BRIEF published on 04/01/2026 at 12:35, 7 months 6 days ago Immunic Achieves Nasdaq Compliance Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
PRESS RELEASE published on 04/01/2026 at 12:30, 7 months 6 days ago Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases
Published on 11/06/2026 at 22:15, 18 hours 4 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 3 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 3 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 3 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 2 hours 44 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 20 hours 4 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 20 hours 4 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 21 hours 4 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 21 hours 19 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 19:06, 21 hours 13 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 21 hours 15 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 21 hours 17 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 21 hours 19 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
